开窗腔内修复与开放手术治疗近肾腹主动脉瘤的比较
本研究回顾性纳入2005至2015年单中心191例择期治疗的近肾腹主动脉瘤患者,比较开窗腔内修复(F-EVAR,57例)与开放手术(OSR,134例)的手术风险及早期和晚期死亡率。F-EVAR组年龄更大、手术风险更高,但30天死亡率无显著差异,5年生存率亦无显著差异。
要点
- F-EVAR组患者年龄更大、Lee评分≥2和ASA 3-4级比例更高。
- 30天死亡率OSR为1.5%、F-EVAR为0%,无统计学差异。
- 5年生存率OSR为82.1%、F-EVAR为69.2%,无显著差异。
核心结论
- 尽管F-EVAR组手术风险更高,但两组术后30天死亡率无显著差异。
- F-EVAR与OSR治疗近肾腹主动脉瘤具有互补性。
研究设计与样本
- 按解剖分类排除肾上腹主动脉瘤,比较F-EVAR组(n=57)与OSR组(n=134)。
- 主要终点为30天死亡率,同时比较5年生存率。
主要发现
- F-EVAR组年龄显著大于OSR组(P=.001)。
- OSR组ICU住院时间显著更长(3.4天 vs 1.5天;P=.01)。
- F-EVAR组Lee评分≥2比例显著更高(21% vs 8.9%;P=.02)。
- F-EVAR组ASA 3-4级比例显著更高(73.6% vs 32.8%;P=.001)。
- 30天死亡率OSR为1.5%、F-EVAR为0%(P=.394);5年生存率OSR为82.1%、F-EVAR为69.2%,均无显著差异。
临床怎么用
- 对于手术风险较高的近肾腹主动脉瘤患者,F-EVAR可作为OSR的互补选择。
- 治疗决策应结合解剖分类、Lee评分和ASA分级综合评估。
局限性
- 回顾性单中心研究,样本量有限,可能存在选择偏倚。
- F-EVAR组年龄和手术风险更高,组间基线不可比。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to compare surgical risk and early and late mortality of patients treated for anatomically classified juxtarenal aortic aneurysms (JRAs) by fenestrated endovascular aneurysm repair (F-EVAR) or open surgical repair (OSR) during a period when the two treatments were available and to validate an institutional algorithm for JRA repair. METHODS: We retrospectively included all patients treated electively in our center between January 2005 and December 2015 for JRAs classified into three anatomic categories, excluding suprarenal aneurysms. Lee score and American Society of Anesthesiologists (ASA) class evaluated preoperative surgical risk. We compared clinical and radiologic parameters between the patients treated by F-EVAR and those treated by OSR. The primary study end point was 30-day mortality. We also compared 5-year survival. RESULTS: From 2005 to 2015, there were 191 patients separated into two groups, one treated by OSR (n = 134; mean age, 69 years) and the other treated by F-EVAR (n = 57; mean age, 74 years). Patients of the F-EVAR group were significantly older (P = .001). Intensive care unit length of stay was significantly higher in the OSR group (3.4 days vs 1.5 days; P = .01). Surgical risk was significantly higher in the F-EVAR group as measured by Lee score ≥2 (OSR, 8.9 %; F-EVAR, 21%; P = .02) and ASA class 3 and class 4 (OSR, 32.8%; F-EVAR, 73.6%; P = .001), whereas 30-day postoperative mortality was not significantly different (OSR, 1.5%; F-EVAR, 0%; P = .394). The 5-year survival was not significantly different in the two groups (OSR, 82.1%; F-EVAR, 69.2%). CONCLUSIONS: In this study, despite a higher surgical risk by Lee score and higher ASA class in the group of patients treated by F-EVAR, postoperative mortality was not significantly different between these groups. In our opinion, F-EVAR and OSR of JRA are complementary.
引用
- Soler R, Bartoli MA, Faries C, et al. Fenestrated endovascular aneurysm repair and open surgical repair for the treatment of juxtarenal aortic aneurysms. J Vasc Surg. 2019. PMID: 30850294. doi:10.1016/j.jvs.2018.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。